These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 26314773)

  • 1. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Tilly H; Gomes da Silva M; Vitolo U; Jack A; Meignan M; Lopez-Guillermo A; Walewski J; André M; Johnson PW; Pfreundschuh M; Ladetto M;
    Ann Oncol; 2015 Sep; 26 Suppl 5():v116-25. PubMed ID: 26314773
    [No Abstract]   [Full Text] [Related]  

  • 2. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Tilly H; Vitolo U; Walewski J; da Silva MG; Shpilberg O; André M; Pfreundschuh M; Dreyling M;
    Ann Oncol; 2012 Oct; 23 Suppl 7():vii78-82. PubMed ID: 22997459
    [No Abstract]   [Full Text] [Related]  

  • 3. JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-5-diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS).
    Ohmachi K
    Int J Hematol; 2019 Aug; 110(2):131-146. PubMed ID: 31177376
    [No Abstract]   [Full Text] [Related]  

  • 4. Diffuse large B-cell non-Hodgkin's lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Tilly H; Dreyling M;
    Ann Oncol; 2008 May; 19 Suppl 2():ii67-9. PubMed ID: 18456774
    [No Abstract]   [Full Text] [Related]  

  • 5. De Novo CD5+ Primary Gastrointestinal Diffuse Large B-Cell Lymphoma: Challenges With Treatment and Clinical Course.
    Ramachandran P; Sahni S; Wang JC
    J Investig Med High Impact Case Rep; 2019; 7():2324709619893546. PubMed ID: 31814435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of newly diagnosed large cell non-Hodgkin's lymphoma.
    Ann Oncol; 2001 Sep; 12(9):1209-10. PubMed ID: 11697826
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical approach to diffuse large B cell lymphoma.
    Caimi PF; Hill BT; Hsi ED; Smith MR
    Blood Rev; 2016 Nov; 30(6):477-491. PubMed ID: 27596109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of diffuse large B-cell lymphoma (DLBCL).
    Kubuschok B; Held G; Pfreundschuh M
    Cancer Treat Res; 2015; 165():271-88. PubMed ID: 25655614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse large B-cell lymphoma: current strategies and future directions.
    Cultrera JL; Dalia SM
    Cancer Control; 2012 Jul; 19(3):204-13. PubMed ID: 22710896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gray Zone Lymphoma: Current Diagnosis and Treatment Options.
    Pilichowska M; Kritharis A; Evens AM
    Hematol Oncol Clin North Am; 2016 Dec; 30(6):1251-1260. PubMed ID: 27888879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remaining challenges in predicting patient outcomes for diffuse large B-cell lymphoma.
    Harkins RA; Chang A; Patel SP; Lee MJ; Goldstein JS; Merdan S; Flowers CR; Koff JL
    Expert Rev Hematol; 2019 Nov; 12(11):959-973. PubMed ID: 31513757
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary Diffuse Large B-cell Lymphoma involving the Mandible.
    Alshahrani FA; Aljabab AS; Motabi IH; Alrashed A; Anil S
    J Contemp Dent Pract; 2015 Oct; 16(10):840-4. PubMed ID: 26581467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using the pathology report in initial treatment decisions for diffuse large B-cell lymphoma: time for a precision medicine approach.
    Friedberg JW
    Hematology Am Soc Hematol Educ Program; 2015; 2015():618-24. PubMed ID: 26637779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological analysis of sinonasal malignant lymphoma in an HTLV-1 endemic area in Japan -special focus on primary sinonasal diffuse large B-cell lymphoma.
    Murakami D; Miyashita K; Koyama T; Omori H; Miyamoto Y; Sawatsubashi M; Nakagawa T
    J Clin Exp Hematop; 2019 Sep; 59(3):101-107. PubMed ID: 31391402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of immunophenotype to the investigation and differential diagnosis of Burkitt lymphoma, double-hit high-grade B-cell lymphoma, and single-hit MYC-rearranged diffuse large B-cell lymphoma.
    Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Liapis K; Gortzolidis G; Kostopoulos IV; Marinakis T; Paterakis G
    Cytometry B Clin Cytom; 2020 Sep; 98(5):412-420. PubMed ID: 32497402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of primary gastric diffuse large B-cell lymphoma: Clinical diagnosis, staging, treatment and prognostic factors.
    Bai Z; Zhou Y
    Leuk Res; 2021 Dec; 111():106716. PubMed ID: 34627052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of long noncoding RNA PEG10 associates with poor prognosis in diffuse large B cell lymphoma with facilitating tumorigenicity.
    Peng W; Fan H; Wu G; Wu J; Feng J
    Clin Exp Med; 2016 May; 16(2):177-82. PubMed ID: 25864113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chinese guidelines for diagnosis and treatment of diffuse large B cell lymphoma(2013)].
    ;
    Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):816-9. PubMed ID: 24103886
    [No Abstract]   [Full Text] [Related]  

  • 19. Diffuse large B-cell lymphoma.
    Li S; Young KH; Medeiros LJ
    Pathology; 2018 Jan; 50(1):74-87. PubMed ID: 29167021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapsed large B-cell non-Hodgkin's lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    ; Jost L
    Ann Oncol; 2007 Apr; 18 Suppl 2():ii57-8. PubMed ID: 17491049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 39.